SNBIF (SanBio Co) Other Financing: $0.00 Mil (TTM As of Jan. 2026)


SNBIF SanBio Co Ltd SNBIF
22 GF Score
Price $16.45
! 1 Warning Sign
View Full Analysis

What is SanBio Co Other Financing?

SanBio Co SNBIF 22 Other Financing is $0.00 Mil as of Jan. 2026. GuruFocus rates SNBIF with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

SanBio Co's Other Financing for the three months ended in Jan. 2026 was $0.00 Mil.

SanBio Co's Other Financing for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00 Mil.

SanBio Co Other Financing Historical Data

* Premium members only.

The historical data trend for SanBio Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SanBio Co Other Financing Chart

SanBio Co Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 0.62 -0.09 -0.09 6.61

SanBio Co Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SNBIF
22GF Score
SanBio Co Ltd SNBIF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SanBio Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.00 Mil mean?
SanBio Co (SNBIF) has a Other Financing of $0.00 Mil as of Jan. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for SanBio Co and its competitors.
Is SanBio Co's Other Financing too high?
SanBio Co's current Other Financing is $0.00 Mil. Overall, SanBio Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does SanBio Co's Other Financing compare to VRTX and REGN?
SanBio Co's Other Financing of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for SanBio Co and its competitors. SanBio Co's current Other Financing is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SanBio Co stock overvalued right now?
SanBio Co (SNBIF) has a current Other Financing of $0.00 Mil. The current Other Financing is $0.00 Mil. SanBio Co's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For SanBio Co (SNBIF), the current Other Financing is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SanBio Co Business Description

Other Exchanges 4592:Japan
Address 8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
22GF Score

Get the complete analysis for SNBIF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.45
Price